amlodipine besilate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
APO-OLMESARTAN/AMLODIPINE/HCTZ 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack
AUST R: 312004
Active ingredients:
amlodipine besilate
hydrochlorothiazide
olmesartan medoxomil

Dosage form:
Tablet, film coated

Sponsor:
Arrotex Pharmaceuticals Pty Ltd

Phone:
1800 195 055

From
23 Oct 2025
to
19 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative brands are available.

CADIVAST 10/10 amlodipine (as besilate) and atorvastatin (as calcium) 10 mg/10 mg tablets bottle
AUST R: 199215
Active ingredients:
amlodipine besilate
atorvastatin calcium trihydrate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
11 Jul 2025
to
15 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An alternative brand is available.

CADIVAST 5/40 amlodipine (as besilate) and atorvastatin (as calcium) 5 mg/40 mg tablets bottle
AUST R: 199214
Active ingredients:
amlodipine besilate
atorvastatin calcium trihydrate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
26 May 2025
to
14 Nov 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An alternative generic product is available.

OLMEKAR 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablet blister pack
AUST R: 290077
Active ingredients:
amlodipine besilate
olmesartan medoxomil

Dosage form:
Tablet, film coated

Sponsor:
Arrotex Pharmaceuticals Pty Ltd

Phone:
1800 195 055

From
06 Feb 2026
to
27 Mar 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment. Alternative generic products are available.

CADIVAST 10/40 amlodipine (as besilate) and atorvastatin (as calcium) 10 mg/40 mg tablets bottle
AUST R: 199225
Active ingredients:
amlodipine besilate
atorvastatin calcium trihydrate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800 274 276

From
08 Sep 2025
to
13 Nov 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

PRITOR/AMLODIPINE 40 mg/10 mg telmisartan 40 mg/amlodipine (as besilate) 10 mg tablet blister pack
AUST R: 202107
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

PRITOR/AMLODIPINE 40 mg/5 mg telmisartan 40 mg/amlodipine (as besilate) 5 mg tablet blister pack
AUST R: 202106
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

PRITOR/AMLODIPINE 80 mg/10 mg telmisartan 80 mg/amlodipine (as besilate) 10 mg tablet blister pack
AUST R: 202109
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
30 Jan 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

PRITOR/AMLODIPINE 80 mg/5 mg telmisartan 80 mg/amlodipine (as besilate) 5 mg tablet blister pack
AUST R: 202108
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

TWYNSTA 40/5 telmisartan 40 mg/amlodipine 5 mg (as besilate) tablet blister pack
AUST R: 166265
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

TWYNSTA 40/10 telmisartan 40 mg/amlodipine 10 mg (as besilate) tablet blister pack
AUST R: 166264
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
27 Feb 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

TWYNSTA 80/10 telmisartan 80 mg/amlodipine 10 mg (as besilate) tablet blister pack
AUST R: 166266
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

TWYNSTA 80/5 telmisartan 80 mg/amlodipine 5 mg (as besilate) tablet blister pack
AUST R: 166263
Active ingredients:
amlodipine besilate
telmisartan

Dosage form:
Tablet, multilayer

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
0288758800

Deletion from market:
31 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability